NCT02609165View on ClinicalTrials.gov

Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Retinitis PigmentosaCystoid Macular Edema
Interventions
DRUG

rhNGF 180 µg/ml eye drops solution

eye drops

DRUG

vehicle eye drops

placebo

Trial Locations (2)

20132

Ospedale San Raffaele, Milan

Unknown

Ospedale Sacco, Milan

All Listed Sponsors
collaborator

Dompé Farmaceutici S.p.A

INDUSTRY

lead

Ospedale San Raffaele

OTHER

NCT02609165 - Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema | Biotech Hunter | Biotech Hunter